Inhibrx Biosciences Statistics
Total Valuation
INBX has a market cap or net worth of $335.99 million. The enterprise value is $261.42 million.
Important Dates
The last earnings date was Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INBX has 14.48 million shares outstanding. The number of shares has increased by 15.09% in one year.
| Current Share Class | 14.48M |
| Shares Outstanding | 14.48M |
| Shares Change (YoY) | +15.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.02% |
| Owned by Institutions (%) | 45.89% |
| Float | 7.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 260.48 |
| Forward PS | n/a |
| PB Ratio | 4.98 |
| P/TBV Ratio | 4.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 186.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.98, with a Debt / Equity ratio of 1.56.
| Current Ratio | 4.98 |
| Quick Ratio | 4.82 |
| Debt / Equity | 1.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.97 |
Financial Efficiency
Return on equity (ROE) is -113.71% and return on invested capital (ROIC) is -31.17%.
| Return on Equity (ROE) | -113.71% |
| Return on Assets (ROA) | -26.29% |
| Return on Invested Capital (ROIC) | -31.17% |
| Return on Capital Employed (ROCE) | -57.14% |
| Revenue Per Employee | $8,696 |
| Profits Per Employee | -$1.02M |
| Employee Count | 161 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, INBX has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +106.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +106.31% |
| 50-Day Moving Average | 18.86 |
| 200-Day Moving Average | 14.98 |
| Relative Strength Index (RSI) | 64.16 |
| Average Volume (20 Days) | 102,417 |
Short Selling Information
The latest short interest is 676,803, so 4.68% of the outstanding shares have been sold short.
| Short Interest | 676,803 |
| Short Previous Month | 898,441 |
| Short % of Shares Out | 4.68% |
| Short % of Float | 8.77% |
| Short Ratio (days to cover) | 6.96 |
Income Statement
In the last 12 months, INBX had revenue of $1.40 million and -$163.69 million in losses. Loss per share was -$10.58.
| Revenue | 1.40M |
| Gross Profit | -130.52M |
| Operating Income | -98.95M |
| Pretax Income | n/a |
| Net Income | -163.69M |
| EBITDA | -96.17M |
| EBIT | -98.95M |
| Loss Per Share | -$10.58 |
Full Income StatementBalance Sheet
The company has $186.57 million in cash and $106.79 million in debt, giving a net cash position of $79.78 million or $5.51 per share.
| Cash & Cash Equivalents | 186.57M |
| Total Debt | 106.79M |
| Net Cash | 79.78M |
| Net Cash Per Share | $5.51 |
| Equity (Book Value) | 68.56M |
| Book Value Per Share | 4.74 |
| Working Capital | 155.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$117.11 million and capital expenditures -$284,000, giving a free cash flow of -$117.40 million.
| Operating Cash Flow | -117.11M |
| Capital Expenditures | -284,000 |
| Free Cash Flow | -117.40M |
| FCF Per Share | -$8.11 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -7,068.14% |
| Pretax Margin | -11,692.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |